[Molecular biological strategies in cancer. How effective are the new therapies?].
Kaulen
Hildegard
H
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000628:therapy; D015179:Colorectal Neoplasms / Q000188:drug therapy; D066246:ErbB Receptors / Q000276:immunology; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008967:Molecular Biology / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000601:surgery; D015203:Reproducibility of Results
D020533:Angiogenesis Inhibitors; D066246:ErbB Receptors